Related Experiment Videos
Antiphospholipid syndrome and palindromic rheumatism: a new possible association
Tatiana Reitblat1, Irena Litinsky, Dan Caspi
1Rheumatology Outpatient Clinics, Barzilai Medical Centre, 3 Histadrut St., Ashkelon, and Sourasky Medical Centre, Tel Aviv University, Israel. alex@barzi.health.gov.il
Objective:
The aim of this study was to report six patients with palindromic rheumatism (PR) in whom signs, symptoms, and/or serologic evidence of antiphospholipid syndrome (APS) developed.
Methods:
The medical histories of the patients were reviewed with special emphasis on age, gender, duration of PR, and lapse of time until antiphospholipid antibodies were detected or APS was diagnosed. Three representative cases are described.
Results:
Two patients were women and four were men. Their mean age was 49.3 years (range 36-80), and the mean duration of PR was 5.5 years (range 3-8). In all patients, raised titers of antiphospholipid antibodies were found on two or more occasions. Two patients developed clinical pictures compatible with APS, two showed symptoms which may be attributable for APS, and raised titers of antiphospholipid antibodies were found in only two.
Conclusion:
It seems that the appearance of these two uncommon conditions together is more than coincidental and may point to a previously unreported clinical association.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management